The molecular relationships between apoptosis, autophagy and necroptosis

Seminars in Cell and Developmental Biology

Volumn 39, Issue , 2015, Pages 63-69

  Lalaoui, Najoua ^a,b   Lindqvist, Lisa M ^a,b   Sandow, Jarrod J ^a,b   Ekert, Paul G ^a,b,c  

^a WALTER AND ELIZA HALL INSTITUTE OF MEDICAL RESEARCH   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c ROYAL CHILDREN'S HOSPITAL   (Australia)

Author keywords

Apoptosis; Autophagy; Caspases; Necroptosis

Indexed keywords

CASPASE 8; PROTEIN BCL 2; TUMOR NECROSIS FACTOR RECEPTOR;

APOPTOSIS; AUTOPHAGOSOME; AUTOPHAGY; CELL DEATH; CELL KILLING; CELL PROLIFERATION; CELL STIMULATION; CELL STRESS; CELL STRUCTURE; CONFORMATIONAL TRANSITION; CYTOTOXIC LYMPHOCYTE; HUMAN; IMMUNOBLOTTING; IMMUNOCOMPETENT CELL; MUTAGENESIS; NECROPTOSIS; NONHUMAN; PATHOPHYSIOLOGY; PHYSIOLOGICAL PROCESS; PROTEIN PROTEIN INTERACTION; REVIEW; SIGNAL TRANSDUCTION; TARGET CELL; ANIMAL;

ANIMALS; APOPTOSIS; AUTOPHAGY; CELL DEATH; HUMANS; SIGNAL TRANSDUCTION;

EID: 84928205948     PISSN: 10849521     EISSN: 10963634     Source Type: Journal    
DOI: 10.1016/j.semcdb.2015.02.003     Document Type: Review

References (103)

1. Bouillet P., Metcalf D., Huang D.C., Tarlinton D.M., Kay T.W., Kontgen F., et al. Proapoptotic Bcl-2 relative Bim required for certain apoptotic responses, leukocyte homeostasis, and to preclude autoimmunity. Science 1999, 286:1735-1738.
2. Lindsten T., Thompson C.B. Cell death in the absence of Bax and Bak. Cell Death Differ 2006, 13:1272-1276.
3. Conradt B., Horvitz H.R. The C. elegans protein egl-1 is required for programmed cell death and interacts with the bcl-2-like protein ced-9. Cell 1998, 93:519-529.
4. Ellis H.M., Horvitz H.R. Genetic control of programmed cell death in the nematode C. elegans. Cell 1986, 44:817-829.
5. Tsujimoto Y., Cossman J., Jaffe E., Croce C.M. Involvement of the bcl-2 gene in human follicular lymphoma. Science 1985, 228:1440-1443.
6. Vaux D.L., Cory S., Adams J.M. Bcl-2 gene promotes haemopoietic cell survival and cooperates with c-myc to immortalize pre-B cells. Nature 1988, 335:440-442.
7. Strasser A. The role of BH3-only proteins in the immune system. Nat Rev Immunol 2005, 5:189-200.
8. Westphal D., Dewson G., Czabotar P.E., Kluck R.M. Molecular biology of Bax and Bak activation and action. Biochim Biophys Acta 2011, 1813:521-531.
9. Czabotar P.E., Westphal D., Dewson G., Ma S., Hockings C., Fairlie W.D., et al. Bax crystal structures reveal how BH3 domains activate Bax and nucleate its oligomerization to induce apoptosis. Cell 2013, 152:519-531.
10. Westphal D., Dewson G., Menard M., Frederick P., Iyer S., Bartolo R., et al. Apoptotic pore formation is associated with in-plane insertion of Bak or Bax central helices into the mitochondrial outer membrane. Proc Natl Acad Sci U S A 2014, 111:E4076-E4085.
11. Czabotar P.E., Lessene G., Strasser A., Adams J.M. Control of apoptosis by the BCL-2 protein family: implications for physiology and therapy. Nat Rev Mol Cell Biol 2014, 15:49-63.
12. Kluck R.M., Bossywetzel E., Green D.R., Newmeyer D.D. The release of cytochrome c from mitochondria - a primary site for bcl-2 regulation of apoptosis. Science 1997, 275:1132-1136.
13. Du C., Fang M., Li Y., Li L., Wang X. Smac, a mitochondrial protein that promotes cytochrome c-dependent caspase activation by eliminating IAP inhibition. Cell 2000, 102:33-42.
14. Verhagen A., Ekert P.G., Silke J., Connolly L.M., Reid G.E., Moritz R.L., et al. Identification of DIABLO, a mammalian protein that promotes apoptosis by binding to and antagonizing IAP proteins. Cell 2000, 102:43-53.
15. Susin S.A., Lorenzo H.K., Zamzami N., Marzo I., Snow B.E., Brothers G.M., et al. Molecular characterization of mitochondrial apoptosis-inducing factor. Nature 1999, 397:441-446.
16. Hegde R., Srinivasula S.M., Zhang Z., Wassell R., Mukattash R., Cilenti L., et al. Identification of Omi/HtrA2 as a mitochondrial apoptotic serine protease that disrupts inhibitor of apoptosis protein-caspase interaction. J Biol Chem 2001, 277:432-438.
17. Martins L.M., Iaccarino I., Tenev T., Gschmeissner S., Totty N.F., Lemoine N.R., et al. The serine protease Omi/HtrA2 regulates apoptosis by binding XIAP through a Reaper-like motif. J Biol Chem 2001, M109784200.
18. Suzuki Y., Imai Y., Nakayama H., Takahashi K., Takio K., Takahashi R. A serine protease, HtrA2, is released from the mitochondria and interacts with XIAP, inducing cell death. Mol Cell 2001, 8:613-621.
19. Verhagen A.M., Silke J., Ekert P.G., Pakusch M., Kaufmann H., Connolly L.M., et al. HtrA2 promotes cell death through its serine protease activity and its ability to antagonize inhibitor of apoptosis proteins. J Biol Chem 2001, 277:445-454.
20. Li P., Nijhawan D., Budihardjo I., Srinivasula S.M., Ahmad M., Alnemri E.S., et al. Cytochrome c and datp-dependent formation of apaf-1/caspase-9 complex initiates an apoptotic protease cascade. Cell 1997, 91:479-489.
21. Zou H., Henzel W.J., Liu X.S., Lutschg A., Wang X.D. Apaf-1, a human protein homologous to C. elegans ced-4, participates in cytochrome c-dependent activation of caspase-3. Cell 1997, 90:405-413.
22. Chai J., Du C., Wu J.W., Kyin S., Wang X., Shi Y. Structural and biochemical basis of apoptotic activation by Smac/DIABLO. Nature 2000, 406:855-862.
23. van Loo G., van Gurp M., Depuydt B., Srinivasula S.M., Rodriguez I., Alnemri E.S., et al. The serine protease Omi/HtrA2 is released from mitochondria during apoptosis. Omi interacts with caspase-inhibitor XIAP and induces enhanced caspase activity. Cell Death Differ 2002, 9:20-26.
24. Yang Q.H., Church-Hajduk R., Ren J., Newton M.L., Du C. Omi/HtrA2 catalytic cleavage of inhibitor of apoptosis (IAP) irreversibly inactivates IAPs and facilitates caspase activity in apoptosis. Genes Dev 2003, 17:1487-1496.
25. Nagata S. Apoptotic DNA fragmentation. Exp Cell Res 2000, 256:12-18.
26. Hoves S., Trapani J.A., Voskoboinik I. The battlefield of perforin/granzyme cell death pathways. J Leukoc Biol 2010, 87:237-243.
27. Waterhouse N.J., Sedelies K.A., Browne K.A., Wowk M.E., Newbold A., Sutton V.R., et al. A central role for Bid in granzyme B-induced apoptosis. J Biol Chem 2005, 280:4476-4482.
28. Adrain C., Murphy B.M., Martin S.J. Molecular ordering of the caspase activation cascade initiated by the cytotoxic T lymphocyte/natural killer (CTL/NK) protease granzyme B. J Biol Chem 2005, 280:4663-4673.
29. Weitzman S. Approach to hemophagocytic syndromes. Hematology: Am Soc Hematol Educ Program 2011, 2011:178-183.
30. Brennan A.J., Chia J., Trapani J.A., Voskoboinik I. Perforin deficiency and susceptibility to cancer. Cell Death Differ 2010, 17:607-615.
31. Mizushima N., Yoshimori T., Levine B. Methods in mammalian autophagy research. Cell 2010, 140:313-326.
32. Matsui Y., Takagi H., Qu X., Abdellatif M., Sakoda H., Asano T., et al. Distinct roles of autophagy in the heart during ischemia and reperfusion: roles of AMP-activated protein kinase and Beclin 1 in mediating autophagy. Circ Res 2007, 100:914-922.
33. Mizushima N., Yoshimori T. How to interpret LC3 immunoblotting. Autophagy 2007, 3:542-545.
34. Galluzzi L., Bravo-San Pedro J.M., Vitale I., Aaronson S.A., Abrams J.M., Adam D., et al. Essential versus accessory aspects of cell death: recommendations of the NCCD 2015. Cell Death Differ 2014, 22:58-73.
35. Shen S., Kepp O., Michaud M., Martins I., Minoux H., Metivier D., et al. Association and dissociation of autophagy, apoptosis and necrosis by systematic chemical study. Oncogene 2011, 30:4544-4556.
36. Maiuri M.C., Criollo A., Tasdemir E., Vicencio J.M., Tajeddine N., Hickman J.A., et al. BH3-only proteins and BH3 mimetics induce autophagy by competitively disrupting the interaction between Beclin 1 and Bcl-2/Bcl-X(L). Autophagy 2007, 3:374-376.
37. Lindqvist L.M., Heinlein M., Huang D.C., Vaux D.L. Prosurvival Bcl-2 family members affect autophagy only indirectly, by inhibiting Bax and Bak. Proc Natl Acad Sci U S A 2014, 111:8512-8517.
38. Pattingre S., Tassa A., Qu X., Garuti R., Liang X.H., Mizushima N., et al. Bcl-2 antiapoptotic proteins inhibit Beclin 1-dependent autophagy. Cell 2005, 122:927-939.
39. Shimizu S., Kanaseki T., Mizushima N., Mizuta T., Arakawa-Kobayashi S., Thompson C.B., et al. Role of Bcl-2 family proteins in a non-apoptotic programmed cell death dependent on autophagy genes. Nat Cell Biol 2004, 6:1221-1228.
40. Denton D., Shravage B., Simin R., Mills K., Berry D.L., Baehrecke E.H., et al. Autophagy, not apoptosis, is essential for midgut cell death in Drosophila. Curr Biol 2009, 19:1741-1746.
41. Altman B.J., Wofford J.A., Zhao Y., Coloff J.L., Ferguson E.C., Wieman H.L., et al. Autophagy provides nutrients but can lead to Chop-dependent induction of Bim to sensitize growth factor-deprived cells to apoptosis. Mol Biol Cell 2009, 20:1180-1191.
42. Gonzalez P., Mader I., Tchoghandjian A., Enzenmuller S., Cristofanon S., Basit F., et al. Impairment of lysosomal integrity by B10, a glycosylated derivative of betulinic acid, leads to lysosomal cell death and converts autophagy into a detrimental process. Cell Death Differ 2012, 19:1337-1346.
43. Rubinstein A.D., Eisenstein M., Ber Y., Bialik S., Kimchi A. The autophagy protein Atg12 associates with antiapoptotic Bcl-2 family members to promote mitochondrial apoptosis. Mol Cell 2011, 44:698-709.
44. Mills K.R., Reginato M., Debnath J., Queenan B., Brugge J.S. Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) is required for induction of autophagy during lumen formation in vitro. Proc Natl Acad Sci U S A 2004, 101:3438-3443.
45. Yu L., Alva A., Su H., Dutt P., Freundt E., Welsh S., et al. Regulation of an ATG7-Beclin 1 program of autophagic cell death by caspase-8. Science 2004, 304:1500-1502.
46. Drappa J., Vaishnaw A.K., Sullivan K.E., Chu J.L., Elkon K.B. Fas gene mutations in the canale-smith syndrome, an inherited lymphoproliferative disorder associated with autoimmunity. N Engl J Med 1996, 335:1643-1649.
47. Watanabe F.R., Brannan C.I., Copeland N.G., Jenkins N.A., Nagata S. Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis. Nature 1992, 356:314-317.
48. Kischkel F.C., Hellbardt S., Behrmann I., Germer M., Pawlita M., Krammer P.H., et al. Cytotoxicity-dependent APO-1 (Fas/CD95)-associated proteins form a death-inducing signaling complex (DISC) with the receptor. EMBO J 1995, 14:5579-5588.
49. Medema J.P., Scaffidi C., Kischkel F.C., Shevchenko A., Mann M., Krammer P.H., et al. FLICE is activated by association with the CD95 death-inducing signaling complex (DISC). EMBO J 1997, 16:2794-2804.
50. Muzio M., Chinnaiyan A.M., Kischkel F.C., O'Rourke K., Shevchenko A., Ni J., et al. FLICE, a novel FADD-homologous ICE/CED-3-like protease, is recruited to the CD95 (Fas/APO-1) death-inducing signaling complex. Cell 1996, 85:817-827.
51. Micheau O., Tschopp J. Induction of TNF receptor I-mediated apoptosis via two sequential signaling complexes. Cell 2003, 114:181-190.
52. Silke J. The regulation of TNF signalling: what a tangled web we weave. Curr Opin Immunol 2011, 23:620-626.
53. Wong W.W., Gentle I.E., Nachbur U., Anderton H., Vaux D.L., Silke J. RIPK1 is not essential for TNFR1-induced activation of NF-kappaB. Cell Death Differ 2010, 17:482-487.
54. Bertrand M.J.M., Milutinovic S., Dickson K.M., Ho W.C., Boudreault A., Durkin J., et al. cIAP1 and cIAP2 facilitate cancer cell survival by functioning as E3 ligases that promote RIP1 ubiquitination. Mol Cell 2008, p689-p700.
55. Feoktistova M., Geserick P., Kellert B., Dimitrova D.P., Langlais C., Hupe M., et al. cIAPs block Ripoptosome formation, a RIP1/caspase-8 containing intracellular cell death complex differentially regulated by cFLIP isoforms. Mol Cell 2011, 43:449-463.
56. Tenev T., Bianchi K., Darding M., Broemer M., Langlais C., Wallberg F., et al. The Ripoptosome, a signaling platform that assembles in response to genotoxic stress and loss of IAPs. Mol Cell 2011, 43:432-448.
57. Vince J.E., Wong W.W., Khan N., Feltham R., Chau D., Ahmed A.U., et al. IAP antagonists target cIAP1 to induce TNFalpha-dependent apoptosis. Cell 2007, 131:682-693.
58. Kaczmarek A., Vandenabeele P., Krysko D.V. Necroptosis: the release of damage-associated molecular patterns and its physiological relevance. Immunity 2013, 38:209-223.
59. He S., Wang L., Miao L., Wang T., Du F., Zhao L., et al. Receptor interacting protein kinase-3 determines cellular necrotic response to TNF-alpha. Cell 2009, 137:1100-1111.
60. Gunther C., Martini E., Wittkopf N., Amann K., Weigmann B., Neumann H., et al. Caspase-8 regulates TNF-alpha-induced epithelial necroptosis and terminal ileitis. Nature 2011, 477:335-339.
61. Cho Y.S., Challa S., Moquin D., Genga R., Ray T.D., Guildford M., et al. Phosphorylation-driven assembly of the RIP1-RIP3 complex regulates programmed necrosis and virus-induced inflammation. Cell 2009, 137:1112-1123.
62. Pan T., Wu S., He X., Luo H., Zhang Y., Fan M., et al. Necroptosis takes place in human immunodeficiency virus type-1 (HIV-1)-infected CD4+ T lymphocytes. PLOS ONE 2014, 9:e93944.
63. Robinson N., McComb S., Mulligan R., Dudani R., Krishnan L., Sad S. Type I interferon induces necroptosis in macrophages during infection with Salmonella enterica serovar Typhimurium. Nat Immunol 2012, 13:954-962.
64. Wang X., Li Y., Liu S., Yu X., Li L., Shi C., et al. Direct activation of RIP3/MLKL-dependent necrosis by herpes simplex virus 1 (HSV-1) protein ICP6 triggers host antiviral defense. Proc Natl Acad Sci U S A 2014, 111:15438-15443.
65. Vercammen D., Beyaert R., Denecker G., Goossens V., Van Loo G., Declercq W., et al. Inhibition of caspases increases the sensitivity of L929 cells to necrosis mediated by tumor necrosis factor. J Exp Med 1998, 187:1477-1485.
66. Vercammen D., Brouckaert G., Denecker G., Van de Craen M., Declercq W., Fiers W., et al. Dual signaling of the Fas receptor: initiation of both apoptotic and necrotic cell death pathways. J Exp Med 1998, 188:919-930.
67. Holler N., Zaru R., Micheau O., Thome M., Attinger A., Valitutti S., et al. Fas triggers an alternative, caspase-8-independent cell death pathway using the kinase RIP as effector molecule. Nat Immunol 2000, 1:489-495.
68. Wilson C.A., Browning J.L. Death of HT29 adenocarcinoma cells induced by TNF family receptor activation is caspase-independent and displays features of both apoptosis and necrosis. Cell Death Differ 2002, 9:1321-1333.
69. Ch'en I.L., Beisner D.R., Degterev A., Lynch C., Yuan J., Hoffmann A., et al. Antigen-mediated T cell expansion regulated by parallel pathways of death. Proc Natl Acad Sci U S A 2008, 105:17463-17468.
70. Thapa R.J., Nogusa S., Chen P., Maki J.L., Lerro A., Andrake M., et al. Interferon-induced RIP1/RIP3-mediated necrosis requires PKR and is licensed by FADD and caspases. Proc Natl Acad Sci U S A 2013, 110:E3109-E3118.
71. Basit F., Cristofanon S., Fulda S. Obatoclax (GX15-070) triggers necroptosis by promoting the assembly of the necrosome on autophagosomal membranes. Cell Death Differ 2013, 20:1161-1173.
72. Chromik J., Safferthal C., Serve H., Fulda S. Smac mimetic primes apoptosis-resistant acute myeloid leukaemia cells for cytarabine-induced cell death by triggering necroptosis. Cancer Lett 2014, 344:101-109.
73. Han W., Li L., Qiu S., Lu Q., Pan Q., Gu Y., et al. Shikonin circumvents cancer drug resistance by induction of a necroptotic death. Mol Cancer Ther 2007, 6:1641-1649.
74. Kaiser W.J., Sridharan H., Huang C., Mandal P., Upton J.W., Gough P.J., et al. Toll-like receptor 3-mediated necrosis via TRIF, RIP3, and MLKL. J Biol Chem 2013, 288:31268-31279.
75. Kalai M., Van Loo G., Vanden Berghe T., Meeus A., Burm W., Saelens X., et al. Tipping the balance between necrosis and apoptosis in human and murine cells treated with interferon and dsRNA. Cell Death Differ 2002, 9:981-994.
76. Ma Y., Temkin V., Liu H., Pope R.M. NF-kappaB protects macrophages from lipopolysaccharide-induced cell death: the role of caspase 8 and receptor-interacting protein. J Biol Chem 2005, 280:41827-41834.
77. Davis C.W., Hawkins B.J., Ramasamy S., Irrinki K.M., Cameron B.A., Islam K., et al. Nitration of the mitochondrial complex I subunit NDUFB8 elicits RIP1- and RIP3-mediated necrosis. Free Radic Biol Med 2010, 48:306-317.
78. Upton J.W., Kaiser W.J., Mocarski E.S. DAI/ZBP1/DLM-1 complexes with RIP3 to mediate virus-induced programmed necrosis that is targeted by murine cytomegalovirus vIRA. Cell Host Microbe 2012, 11:290-297.
79. O'Donnell M.A., Legarda-Addison D., Skountzos P., Yeh W.C., Ting A.T. Ubiquitination of RIP1 regulates an NF-kappaB-independent cell-death switch in TNF signaling. Curr Biol 2007, 17:418-424.
80. Bonnet M.C., Preukschat D., Welz P.S., van Loo G., Ermolaeva M.A., Bloch W., et al. The adaptor protein FADD protects epidermal keratinocytes from necroptosis in vivo and prevents skin inflammation. Immunity 2011, 35:572-582.
81. Zhang J., Zhang H., Li J., Rosenberg S., Zhang E.C., Zhou X., et al. RIP1-mediated regulation of lymphocyte survival and death responses. Immunol Res 2011, 51:227-236.
82. Li J., McQuade T., Siemer A.B., Napetschnig J., Moriwaki K., Hsiao Y.S., et al. The RIP1/RIP3 necrosome forms a functional amyloid signaling complex required for programmed necrosis. Cell 2012, 150:339-350.
83. Sun L., Wang H., Wang Z., He S., Chen S., Liao D., et al. Mixed lineage kinase domain-like protein mediates necrosis signaling downstream of RIP3 kinase. Cell 2012, 148:213-227.
84. Cai Z., Jitkaew S., Zhao J., Chiang H.C., Choksi S., Liu J., et al. Plasma membrane translocation of trimerized MLKL protein is required for TNF-induced necroptosis. Nat Cell Biol 2014, 16:55-65.
85. Chen X., Li W., Ren J., Huang D., He W.T., Song Y., et al. Translocation of mixed lineage kinase domain-like protein to plasma membrane leads to necrotic cell death. Cell Res 2014, 24:105-121.
86. Dondelinger Y., Declercq W., Montessuit S., Roelandt R., Goncalves A., Bruggeman I., et al. MLKL compromises plasma membrane integrity by binding to phosphatidylinositol phosphates. Cell Rep 2014, 7:971-981.
87. Hildebrand J.M., Tanzer M.C., Lucet I.S., Young S.N., Spall S.K., Sharma P., et al. Activation of the pseudokinase MLKL unleashes the four-helix bundle domain to induce membrane localization and necroptotic cell death. Proc Natl Acad Sci U S A 2014, 111:15072-15077.
88. Murphy J.M., Czabotar P.E., Hildebrand J.M., Lucet I.S., Zhang J.G., Alvarez-Diaz S., et al. The pseudokinase MLKL mediates necroptosis via a molecular switch mechanism. Immunity 2013, 39:443-453.
89. Wang H., Sun L., Su L., Rizo J., Liu L., Wang L.F., et al. Mixed lineage kinase domain-like protein MLKL causes necrotic membrane disruption upon phosphorylation by RIP3. Mol Cell 2014, 54:133-146.
90. Kearney C.J., Cullen S.P., Clancy D., Martin S.J. RIPK1 can function as an inhibitor rather than an initiator of RIPK3-dependent necroptosis. FEBS J 2014, 281:4921-4934.
91. Orozco S., Yatim N., Werner M.R., Tran H., Gunja S.Y., Tait S.W., et al. RIPK1 both positively and negatively regulates RIPK3 oligomerization and necroptosis. Cell Death Differ 2014, 21:1511-1521.
92. Kaiser W.J., Upton J.W., Long A.B., Livingston-Rosanoff D., Daley-Bauer L.P., Hakem R., et al. RIP3 mediates the embryonic lethality of caspase-8-deficient mice. Nature 2011, 471:368-372.
93. Rickard J.A., O'Donnell J.A., Evans J.M., Lalaoui N., Poh A.R., Rogers T., et al. RIPK1 regulates RIPK3-MLKL-driven systemic inflammation and emergency hematopoiesis. Cell 2014, 157:1175-1188.
94. Upton J.W., Kaiser W.J., Mocarski E.S. Virus inhibition of RIP3-dependent necrosis. Cell Host Microbe 2010, 7:302-313.
95. Chang D.W., Xing Z., Pan Y., Algeciras-Schimnich A., Barnhart B.C., Yaish-Ohad S., et al. c-FLIP(L) is a dual function regulator for caspase-8 activation and CD95-mediated apoptosis. EMBO J 2002, 21:3704-3714.
96. Pop C., Oberst A., Drag M., Van Raam B.J., Riedl S.J., Green D.R., et al. FLIP(L) induces caspase 8 activity in the absence of interdomain caspase 8 cleavage and alters substrate specificity. Biochem J 2011, 433:447-457.
97. Oberst A., Dillon C.P., Weinlich R., McCormick L.L., Fitzgerald P., Pop C., et al. Catalytic activity of the caspase-8-FLIP(L) complex inhibits RIPK3-dependent necrosis. Nature 2011, 471:363-367.
98. Dillon C.P., Oberst A., Weinlich R., Janke L.J., Kang T.B., Ben-Moshe T., et al. Survival function of the FADD-CASPASE-8-cFLIP(L) complex. Cell Rep 2012, 1:401-407.
99. Hitomi J., Christofferson D.E., Ng A., Yao J., Degterev A., Xavier R.J., et al. Identification of a molecular signaling network that regulates a cellular necrotic cell death pathway. Cell 2008, 135:1311-1323.
100. Moquin D.M., McQuade T., Chan F.K. CYLD deubiquitinates RIP1 in the TNFalpha-induced necrosome to facilitate kinase activation and programmed necrosis. PLOS ONE 2013, 8:e76841.
101. O'Donnell M.A., Perez-Jimenez E., Oberst A., Ng A., Massoumi R., Xavier R., et al. Caspase 8 inhibits programmed necrosis by processing CYLD. Nat Cell Biol 2011, 13:1437-1442.
102. Bell B.D., Leverrier S., Weist B.M., Newton R.H., Arechiga A.F., Luhrs K.A., et al. FADD and caspase-8 control the outcome of autophagic signaling in proliferating T cells. Proc Natl Acad Sci U S A 2008, 105:16677-16682.
103. Lu J.V., Weist B.M., van Raam B.J., Marro B.S., Nguyen L.V., Srinivas P., et al. Complementary roles of Fas-associated death domain (FADD) and receptor interacting protein kinase-3 (RIPK3) in T-cell homeostasis and antiviral immunity. Proc Natl Acad Sci U S A 2011, 108:15312-15317.